1 / 18

Adherence: Easy to Define but Difficult to Measure

Overview of Issues in Measuring Adherence to Therapy for Chronic Illness Using Electronic Databases and Other Methods Dennis Ross-Degnan Harvard Medical School and Harvard Pilgrim Health Care. Adherence: Easy to Define but Difficult to Measure.

Download Presentation

Adherence: Easy to Define but Difficult to Measure

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Overview of Issues in Measuring Adherence to Therapy for Chronic Illness Using Electronic Databases and Other Methods Dennis Ross-Degnan Harvard Medical School and Harvard Pilgrim Health Care

  2. Adherence: Easy to Define but Difficult to Measure “the extent to which a person’s behavior – taking medication, following a diet, and/or executing lifestyle changes – corresponds with agreed recommendations from a health care provider” WHO Adherence to Long-Term Therapies Project

  3. Uses of Reliable Measures of Adherence to Long-term Therapy • Clinical • Improve individual patient care • Target interventions to patients at risk • Behavioral research • Determinants of adherence • Barriers to improved adherence • Health services research • Relationships among adherence, clinical response, service use, and outcomes • Monitor program effectiveness

  4. Methods to Assess Adherence to Long-Term Medications • Subjective measures • Physician chart entry or report • Patient or caretaker report or diary • Objective measures • Pill counts: counting remaining medicines, dispensing records • Physical tests: pharmacologic (serum or urine levels), physiologic (e.g., HbA1c) • Medication Event Monitoring Systems

  5. Methods to Assess Treatment Adherence in 513 (314 Medication ) Studies Average adherence rates observed: 85.1% Objective Methods: 80.2% 72.9% 69.0% 72.6% Subjective Methods: 71.8% 71.8% 66,6% Source: DiMatteo, Medical Care 2004; 42(3): 200-209

  6. Comparison of Adherence to Medications vs. Other Therapeutic Regimens Number of regimens: 328 9 13 88 57 25 Source: DiMatteo, Medical Care 2004; 42(3): 200-209

  7. Average Adherence to Therapy in Studies of Selected Disease Conditions Number of studies: 8 22 42 65 9 17 129 19 34 20 41 23 16 Source: DiMatteo, Medical Care 2004; 42(3): 200-209

  8. Demographic Factors as Correlates of Adherence • Age: Relationship varies widely • Children: higher in young vs. adolescents • Adult: Self-report negatively associated but other measures positively associated • Gender: In adults no relationship, in children, females more adherent • Education: Positively associated, mainly for chronic illness • Income/SES: Positively associated • Mostly studies using numeric income measures • Primarily in adult samples Source: DiMatteo, Medical Care 2004; 42(3): 200-209

  9. Choosing Subjective vs. Objective Methods • No gold standard • Subjective • Can be direct, simple, inexpensive • Differences in respondent framing, interpretation • Potential bias (recall, social desirability, self-perception) but not inflated in meta-analysis • Objective • Difficult to measure key concepts of interest • Generally more expensive and complex • Potential for missing and unreliable data

  10. Types of Information in Electronic Dispensing Records • Identification of drug • Name, unique code, strength • Indication or diagnosis (usually not available) * • Measures of amount • Quantity dispensed • Cost of medication • Indication of intended regimen • Dosage instructions * • Days’ supply dispensed * * Data are usually less reliable in most systems

  11. Dispensing-based Adherence Measures: Positives and Negatives • Validity and Reliability • Can measure long-term patterns • Uncertain relation to actual use • No measure of actual timing of use • Missing data • Feasibility and Cost • Often derived from electronic data collected for other purposes • Requires sophisticated data handling

  12. Types of Adherence Measures Derived From Dispensing Data • Continuous (e.g., % of expected dose taken) vs. dichotomous (e.g., if >80% of expected dose taken) • Single (2 fills) vs. multiple (many fills) intervals • Medication availability vs. gaps in availability during fixed measurement window Source: Steiner JF et al. J Clin Epidemiol 1997; 50(1), 105-116

  13. Some Possible Measures of Adherence from Dispensing Data • Primary non-adherence • Does not fill a prescription in <#> days • Adherence • # days of medicine available divided by # of days in a period (but not > 1.0?) • Gap in treatment • # days between dispensings greater than # days supplied in first dispensing • Discontinuation • Treatment gap more than <#> days (30?)

  14. Fill date = 0 30 75 130 210 Gap length 15 25 40 1.0 1.0 0.5 0.7 1.0 1.0 1.0 1.0 1.0 0.7 0.0 Adherence Discontinued Measuring Adherence Using Dispensing Data 0.5 Adapted from: Steiner JF et al. J Clin Epidemiol 1997; 50(1), 105-116

  15. Problems in Interpreting Dispensing-Based Measures • Unreliable information biases measures • Dosage regimen or days supply • Unrecorded changes in regimen • Missing dispensings • Uncertainty about dynamics of observed consumption • Timing of doses • How distributed over time • Whether discontinued

  16. General Recommendations in Measuring Long-term Adherence • Important to validate data reliability and completeness • Triangulate using both objective and subjective indicators • Medication consumption, OPD visits • Reported adherence behaviors • Reported reasons for non-adherence • Clinical correlates

  17. Special Case: Measuring Adherence to ARVs • Key issues: • ART requires continuous tight adherence • Complex socio-behavioral context • Minimum indicators should include • Overall medication consumption • Dose consistency and timing • Reported reasons for inconsistent adherence • Frequency and severity of reported side effects • Consistency of clinical visits • Key physiological measures (CD4) • Patient, care provider, and clinician attitudes

More Related